Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SpeeDx (Australia)

SpeeDx (Australia)
Later Stage VC LATEST DEAL TYPE (In Progress)

Provider of molecular diagnostics solutions intended to develop innovative multiplex systems for clinical diagnostics. The company uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Suite G16, National Innovation Centre
  • Australian Technology Park, 4 Cornwallis Street, Eveleigh
  • Sydney, New South Wales 2015
  • Australia

+61 (02) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SpeeDx (Australia)’s full profile, request a free trial.

SpeeDx (Australia) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 14-Jul-2018 00.000 In Progress Generating Revenue
7. Grant 04-Sep-2017 00.000 00.000 Completed Generating Revenue
6. Later Stage VC (Series A) 01-Jan-2017 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 01-Jul-2016 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
2. Grant 11-May-2014 $1.8M Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

SpeeDx (Australia) Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Global Connections Fund Other 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0
New South Wales Medical Device Fund Corporation 000 0000 000000 0
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
Johnson & Johnson Corporation Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

SpeeDx (Australia) Executive Team (4)

Name Title Board
Colin Denver Chief Executive Officer
Elisa Mokany Ph.D Co-Founder & Chief Technology Officer
Alison Todd Ph.D Co-Founder & Chief Scientific Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

SpeeDx (Australia) Board Members (3)

Name Representing Role Since Contact
Andrew Denver Self Chairman 000 0000
Andrew Jane Self Board Member 000 0000
John Klopp SpeeDx (Australia) Board Member 000 0000